Within this concept, our DE findings also support the role of hsa‐miR‐155p modulation in LS pathogenesis even though the performed in silico analysis could not identify MMR‐genes as targets of hsa‐miR‐155‐5p. This evidence concerns the gene MRC1 and Leigh syndrome.